Real-world safety of HPV vaccines over 18 y: A comprehensive analysis of U.S. VAERS reports
Human papillomavirus (HPV) vaccination is central to preventing cervical and other HPV-associated cancers. Although clinical trials have established favorable safety profiles, long-term, brand-specific real-world data remain limited. We evaluated adverse events (AEs) reported to the U.S. Vaccine Adv...
Saved in:
Main Authors: | Yonglong Su, Yirong Huang, Jinbao Wei, Xinjin Wang, Yanyan Zhou, Xiaohong Wu, Honghong Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2539590 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vaccine Safety International Monitoring
by: M. A. Darmostukova, et al.
Published: (2019-03-01) -
Knowledge, attitude, and perception of the parents toward HPV vaccine administration to their children in Saudi Arabia: a cross-sectional study
by: Abubaker S. Bakhashab, et al.
Published: (2025-07-01) -
Evaluation of Anti-HPV18 Antibody Titers Preceding an Incident Cervical HPV18/45 Infection
by: Fanua Wiek, et al.
Published: (2025-07-01) -
Benefits of Gender-Neutral Vaccination Strategy for the Prevention of HPV-Associated Diseases and the Eradication of HPV Infection in General. Current State of HPV Vaccination in the World
by: Tatiana E. Privalova, et al.
Published: (2021-07-01) -
Overcoming HPV Vaccine Hesitancy in Japan: A Narrative Review of Safety Evidence, Risk Communication, and Policy Approaches
by: Takayuki Takahashi, et al.
Published: (2025-05-01)